The present disclosure relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.La présente invention concerne des anticorps anti-AXL, des immunoconjugués, des compositions et une méthode de traitement du cancer faisant intervenir lesdits anticorps anti-AXL, immunoconjugués ou compositions.